Genentech
Overview
Genentech is a biotechnology company dedicated to pursuing groundbreaking science to discover and develop medicines for people with serious and life-threatening diseases . Considered the founder of the industry, Genentech, now a member of the Roche Group, has been delivering on the promise of biotechnology for more than 45 years . Genentech's transformational discoveries include the first targeted antibody for cancer and the first medicine for primary progressive multiple sclerosis .
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Orionis Biosciences | May 2025 | Corporate Funding | Lead |
| Atalanta Therapeutics | Jan 2021 | Series A | Co-investor |
| Arexera Therapeutics | Jan 2021 | Series A | Co-investor |
| LumaCyte | Aug 2019 | Grant | Co-investor |
| Ribometrix | Jan 2021 | Strategic | Lead |
For institutional investors. Book with your work email.
Key People
Louis Vermeulen
Vice President and Senior Fellow, Head of Discovery Oncology
Amber Cottle
Vice President of Government Affairs
Kenneth Berland
Principal Software Engineer
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Genentech based?
Genentech is headquartered in South San Francisco, California, United States.
When was Genentech founded?
Genentech was founded in 1976.
How many portfolio companies does Genentech have?
Genentech has 6 portfolio companies in Caplight's dataset.
What are some companies in Genentech's portfolio?
Portfolio companies visible on Caplight include Orionis Biosciences, Atalanta Therapeutics, Arexera Therapeutics, LumaCyte, Ribometrix.
What was Genentech's most recent investment shown here?
Genentech's most recent investment in this portfolio sample was in Orionis Biosciences in 2025.
What sectors does Genentech focus on?
Genentech focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Consumer & Commerce, Frontier & Industrial Tech.
What company stages does Genentech focus on?
Genentech typically invests at the MultiStage stage.
What is Genentech's AUM?
Genentech's assets under management are estimated at over $100.0B.